Inventiva S.A
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat … Read more
Inventiva S.A (IVEVF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 6.031x
Based on the latest financial reports, Inventiva S.A (IVEVF) has a cash flow conversion efficiency ratio of 6.031x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-53.73 Million) by net assets ($-8.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inventiva S.A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Inventiva S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Inventiva S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inventiva S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Capricorn Energy PLC
PINK:CRNCY
|
0.053x |
|
Gaon Cable
KO:000500
|
0.025x |
|
KNOWIT AB SK 5
F:KOW
|
N/A |
|
Surya Roshni Limited
NSE:SURYAROSNI
|
0.098x |
|
Ipd Group Ltd
AU:IPG
|
0.132x |
|
Qibu Co Ltd
SHG:603557
|
-0.299x |
|
Kogan.com Ltd
PINK:KGGNF
|
0.786x |
|
Shang Gong Group Co Ltd B
SHG:900924
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Inventiva S.A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Inventiva S.A from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-106.65 Million | $-85.93 Million | 0.806x | -68.38% |
| 2023-12-31 | $-32.03 Million | $-81.61 Million | 2.548x | +357.90% |
| 2022-12-31 | $45.48 Million | $-44.93 Million | -0.988x | -84.33% |
| 2021-12-31 | $88.87 Million | $-47.63 Million | -0.536x | -94.85% |
| 2020-12-31 | $111.21 Million | $-30.59 Million | -0.275x | +59.92% |
| 2019-12-31 | $41.39 Million | $-28.40 Million | -0.686x | -23.57% |
| 2018-12-31 | $61.60 Million | $-34.21 Million | -0.555x | -109.07% |
| 2017-12-31 | $64.01 Million | $-17.00 Million | -0.266x | +36.15% |
| 2016-12-31 | $35.72 Million | $-14.86 Million | -0.416x | -27.24% |
| 2015-12-31 | $42.77 Million | $-13.98 Million | -0.327x | -13.88% |
| 2014-12-31 | $51.51 Million | $-14.79 Million | -0.287x | -5.83% |
| 2013-12-31 | $59.01 Million | $-16.01 Million | -0.271x | -- |